Kelly Cathey

Lutonix, Inc. develops and commercializes drug coated balloon catheters. Its catheters help to deliver therapeutic dose of paclitaxel. The firm’s catheters are used to treat peripheral and coronary lesions. The company was founded in July 2007 by Dennis Wahr and Lixiao Wang and is headquartered in New Hope, MN.

Velocimed LLC develops, manufactures, and markets medical devices. The firm's products are used in cardiology and neurology applications. The company was founded in 2001 by Jay Schmelter, Michael Berman, and Dennis W. Wahr and is headquartered in Maple Grove, MN.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

IDEV Technologies, Inc. develops medical devices for endovascular uses. Its products include interventional cardiology, interventional radiology and vascular surgery. The company was founded by Sheldon J. Jeffery in 1999 and is headquartered in Webster, TX.

Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY.

Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO.

Adarza BioSystems, Inc. develops and manufacturers a multiplex immunoassay technology that can identify proteins and genetic markers in medical specimens. The firm operates as a medical diagnostics company which also develops a rapid and label-free biological assay platform for measuring clinical and point-of-care samples and also its technology allows hundreds of tests to be run simultaneously on a single chip. The company was founded by Benjamin L. Miller, Randolph R. Henke, Terry Gronwall and Christopher C. Striemer in 2008 and is headquartered in St. Louis, MO.

3x5 Partners LLC (3x5 Partners) is a venture capital firm founded in 2011 by Tony Arnerich and Nicholas Walrod. The firm is headquartered in Portland, Oregon.

VentureMed Group, Inc. designs, develops, and markets interventional devices for the treatment of peripheral artery disease. Its product platforms are designes to reduce procedural costs and improve clinical outcomes. The company was founded by John P. Pigott in 2012 and is headquartered in Plymouth, MN.

Part of Lazard Ltd., Lazard Frères et Co. is a French company that provides investment advice.

Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA.

BioMed Ventures (BioMed Ventures) is a venture capital firm subsidiary of BioMed Realty founded in 2010. The firm is headquartered in San Diego, California.

Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA.

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

WeedOUT Ltd. is an Israeli company that focuses on exploiting sterility against resistant weeds. The company is based in Ness Ziona, Israel. Orly Noivirt-Brik, Efrat Lidor Nili has been the CEOs since 2016. The company was founded in 2016 by Orly Noivirt-Brik, Efrat Lidor Nili.

Standard Bariatrics, Inc. operates as a surgical procedure company focused on the development and commercialization of medical devices. It offers STANDARD CLAMP, a laparoscopic surgical device designed to clamp the entire length of the stomach, enabling surgeons to plan and hold the staple line prior to dividing the stomach during laparoscopic sleeve gastrectomy. The company was founded by Jonathan Thompson in 2014 and is headquartered in Cincinnati, OH.

Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH.

Forward Ventures Services LLC (Forward Ventures ) is a venture capital firm founded in 1990 by Standish M. Fleming and Ivor Royston. The firm is headquartered in San Diego, California.

BioEnterprise Corp. provides access to capital through both its relationships with venture capital and investment banking firms. It initiates for start up funding, and networking information, recruitment, and emerging support firms, including medical devices companies. The company was founded in 2002 and is headquartered in Cleveland, OH.

Securus Medical Group, Inc. develops clinical tools to monitor core body temperature within body cavities. The firm develops tissue temperature monitoring and mapping systems. The company was founded by John T. Garibotto on June 24, 2011 and is headquartered in Cleveland, OH.

JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY.

The Donald Danforth Plant Science Center is a non-profit research institute founded in 1998 with a mission to improve the human condition through plant science. The non-profit company's research, education, and outreach efforts focus on the intersection of food security and the environment, positioning St. Louis as a world center for plant science. The company is based in St. Louis, MO. The center is funded through competitive grants from various sources, including the National Institutes of Health, Department of Energy, National Science Foundation, and the Bill & Melinda Gates Foundation. The center's principal investigators conduct fundamental research that leads to useful crops and products that solve real problems.

UltraShape redefines aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for fat cell destruction and body sculpting. The company develops and markets clinically proven safe and effective solutions that enhance the lives of patients. The UltraShape proprietary technology employs pulsed (non-thermal) focused ultrasound that instantly, selectively and permanently destroys fat cells without affecting surrounding structures. Founded in 2000, UltraShape has sold Contour I devices in more than 50 countries, demonstrating safety and efficacy. The UltraShape Contour I system, is authorized for marketing outside the U.S. It is the first clinically proven non-invasive solution that offers measurable lasting body sculpting results for men and women with no need for maintenance treatments. The UltraShape system has been shown to be safe and effective in a multi-center controlled trial and numerous other peer-reviewed published independent clinical studies. The device is designed to produce mechanical, non-thermal, acoustic effects which target and selectively destroy (breakdown) fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The latest Contour I V3 system uses Vertical Dynamic Focus™ (VDF) pulsed (non-thermal) focused ultrasound that instantly and permanently destroys fat cells providing patients a convenient noninvasive no-downtime solution to reduce localized fat deposits and body circumference. The UltraShape procedure is based on a natural fat clearance process where triglycerides and cell debris from the destroyed fat cells are processed by the body's natural physiological and metabolic pathways. These pathways are the same that handle fat during weight loss. Results from UltraShape's peer-reviewed published multi-center controlled clinical trial and other independent clinical studies show that the released triglycerides do not accumulate to a clinically significant extent in the blood or liver. Over 200,000 patient treatments have been performed worldwide with the Contour I showing high patient satisfaction while demonstrating safety and efficacy. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guides the operator through a pres-determined treatment algorithm designed to minimize risk of contour irregularities, a common side effect of invasive and non-invasive procedures. The UltraShape procedure is performed during a convenient, 'walk-in, walk-out' session carried out in an office-based environment; it requires no anesthesia or sedation. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The Contour I system is not available for sale in the U.S; the Contour Plus system is an investigational product limited by U.S. law to investigational use only.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.

Part of Medtronic Plc, Mazor Robotics LLC is a company that specializes in the Mazor X Stealth Edition robotic guidance platform. The company is based in Orlando, FL. The platform is equipped with advanced software, robotic technologies, navigation, and instrumentation to support predictable surgical procedures. Christopher Prentice has been the CEO of the company since 2014.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

PulmOne Advanced Medical Devices Ltd. develops devices designed to allow lung function testing. It manufactures and distributes the MiniBox, an office based solution providing complete lung function testing in a portable device. The company was founded by Avi Lazar in 2006 and is headquartered in Raanana, Israel.

ClearCut Medical Ltd. develops proprietary technology and tools for removal of cancer. Its product ClearSightTM MRI System, focuses on breast cancer lumpectomy for intraoperative margin assessment of surgically removed lumps. The firms applications include breast cancer biopsies, margin assessment of skin cancer, prostate cancer, colorectal cancer and lung cancer tissue microstructure. The company was founded by Eyal Kolka and Erez Golan in 2010 and is headquartered in Rehovot, Israel.

InspireMD Ltd. is a medical device company, which engages in the development and commercialization of platform technology for the treatment of vascular and coronary disease. It offers MicroNet stent, a device designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.

Owlytics Healthcare operates personalized physiology-tracking health detection platform. The company was founded by Gill Zaphrir and Yaron Recher in 2015 and is headquartered in Tel Aviv, Israel.

CardiacSense Ltd. is a digital health company based in Caesarea, Israel. The Israeli company has developed a medical watch that integrates proprietary patent-protected sensors and software algorithms to provide continuous measurement of parameters such as core temperature, respiratory rate, blood pressure, oxygen saturation, and heart rate at CE and FDA-mandated accuracies. This provides an alternative to costly and complex invasive devices, addressing the increasing demand for remote patient monitoring and tele-health. The private company was founded in 2009 by Eldad Shemesh and Liat Shemesh, with Eldad Shemesh serving as the CEO since incorporation.

Juvenile Diabetes Research Foundation Canada focuses on type 1 diabetes (T1D) research. The company was founded in 1974 and is headquartered in Toronto, Canada.

Qart Medical Ltd. is a medical, a clinical-stage medtech company, addressing the global infertility epidemic. The company was founded by Alon Shalev and Natan T. Shaked and is headquartered in Israel.

Gordian Group LLC provides financial advisory services. It offers financial advisory, merges and acquisitions, structured finance, access to capital, litigation support, financial options and asset management. The company was founded by Patricia A. Caldwell and Henry Furlow Owsley III in 1998 and is headquartered in New York, NY.